Does Rallies show 13F holders for PROK?

Yes. Rallies tracks hedge fund and 13F ownership data for PROK, including fund names, share counts, latest tracked quarter, and position changes when available.

Is PROK research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PROK. It does not provide personalized investment advice.

PROK (ProKidney Corp. Class A Ordinary Shares) Stock Analysis - Hedge Fund Holdings

ProKidney Corp. Class A Ordinary Shares (PROK) is a publicly traded Healthcare sector company. As of May 21, 2026, PROK trades at $1.74 with a market cap of $330.37M and a P/E ratio of 0.00. PROK moved +10.65% today. Year to date, PROK is -21.03%; over the trailing twelve months it is +113.01%. Its 52-week range spans $0.46 to $7.13. Analyst consensus is neutral with an average price target of $7.33. Rallies surfaces PROK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns PROK stock?

Hedge funds tracked by Rallies that own PROK include Exoduspoint Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for ProKidney Corp. Class A Ordinary Shares.

PROK Key Metrics

Key financial metrics for PROK
Metric	Value
Price	$1.74
Market Cap	$330.37M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$7.13
52-Week Low	$0.46
Volume	290
Avg Volume	0
Revenue (TTM)	$893.00K
Net Income	$-151.61M
Gross Margin	0.00%

Top Hedge Funds Holding PROK

Exoduspoint Capital holds 254.35K shares of PROK, changed +97.40% as of Mar 31, 2026.

Latest PROK News

ProKidney Secures $224.9M Cash, Targets PROACT-1 Enrollment Completion by Mid-2026 — May 15, 2026

Recent PROK Insider Trades

Pereira Brian JG sold 447.80K (~$1.06M) on Nov 13, 2025.
Pereira Brian JG sold 54.33K (~$128.77K) on Nov 13, 2025.
Pereira Brian JG sold 227.43K (~$619.36K) on Nov 12, 2025.

PROK Analyst Consensus

5 analysts cover PROK: 0 strong buy, 2 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $7.33.

Common questions about PROK

Who owns PROK stock?: Hedge funds tracked by Rallies that own PROK include Exoduspoint Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for ProKidney Corp. Class A Ordinary Shares.
Does Rallies show 13F holders for PROK?: Yes. Rallies tracks hedge fund and 13F ownership data for PROK, including fund names, share counts, latest tracked quarter, and position changes when available.
Is PROK research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PROK. It does not provide personalized investment advice.